Risk factors for death in patients with non-infectious adverse events
ABSTRACT Objetive: to identify risk factors for death in patients who have suffered non-infectious adverse events. Method: a retrospective cohort study with patients who had non-infectious Adverse Events (AE) in an Intensive Care Unit. The Kaplan Meier method was used to estimate the conditional probability of death (log-rank test 95%) and the risk factors associated with death through the Cox regression. Results: patients over 50 years old presented a risk 1.57 times higher for death; individuals affected by infection/sepsis presented almost 3 times the risk. Patients with a Simplified Acute Physiology Score III (SAPS3) greater than 60 points had four times higher risk for death, while those with a Charlson scale greater than 1 point had approximately two times higher risk. The variable number of adverse events was shown as a protection factor reducing the risk of death by up to 78%. Conclusion: patients who had suffered an adverse event and who were more than 50 years of age, with infection/sepsis, greater severity, i.e., SAPS 3>30 and Charlson>1, presented higher risk of death. However, the greater number of AEs did not contributed to the increased risk of death.
Main Authors: | Gadelha,Gilcilene Oliveira, Paixão,Hémilly Caroline da Silva, Prado,Patricia Rezende do, Viana,Renata Andréa Pietro Pereira, Amaral,Thatiana Lameira Maciel |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo
2018
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692018000100326 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adverse events in critically ill patients: a cross-sectional study
by: Assis,Stefanny Furtado de, et al.
Published: (2022) -
Adverse event management
by: Vigani,Aline Gonzalez
Published: (2007) -
Adverse events in patients with leprosy on treatment with thalidomide
by: Drummond,Paula Lana de Miranda, et al.
Published: (2019) -
Natalizumab adverse events are rare in patients with multiple sclerosis
by: Fragoso,Yára Dadalti, et al.
Published: (2013) -
Adverse events of vaccines and the consequences of non-vaccination: a critical review
by: Aps,Luana Raposo de Melo Moraes, et al.
Published: (2018)